ImmunArray Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 30
Employees
  • Latest Deal Type
  • Out of Business

ImmunArray General Information

Description

Developer of an in-vitro molecular diagnostics system designed to help physicians manage complex autoimmune and neurologic diseases. The company's system is used in the development of microarray devices and informatics that are used in profiling a patient's immune system to detect autoimmune, lung cancer, and other diseases, providing physicians with information from proprietary multi-analyte biomarker-based tests.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 12 Hamada Street
  • Entrance A - Floor 2
  • Rehovot 7670315
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunArray Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Sep-2020 000.00 Completed Out of Business
7. Later Stage VC (Series B) 11-Jul-2016 0000 000.00 Completed Generating Revenue
6. Grant 23-Jan-2014 00000 00.00 Completed Generating Revenue
5. Later Stage VC 15-Apr-2013 00.00 00.00 Completed Generating Revenue
4. Early Stage VC 03-May-2010 00.00 00.00 Completed Startup
3. Grant 22-Dec-2008 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 25-Feb-2008 Completed Startup
To view ImmunArray’s complete valuation and funding history, request access »

ImmunArray Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an in-vitro molecular diagnostics system designed to help physicians manage complex autoimmune and neurolog
Diagnostic Equipment
Rehovot, Israel
30 As of 2016
000.00
00000000 00 000.00

00000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000000000 000000000
Fremont, CA
000 As of 0000
000
000000000000 000

00000000

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
00 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunArray Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioGenex Laboratories Formerly PE-Backed Fremont, CA 000 000 000000000000 000
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 0000 00000 00000000000
0000000 0000000000 Corporation Carlsbad, CA 000 0000 0&0
00000000 000000000 Formerly VC-backed Dortmund, Germany 00 000.00 000000&0 000.00
0000000 0000000000 Venture Capital-Backed Beverly, MA 00 00.00 0000000000 00.00
You’re viewing 5 of 38 competitors. Get the full list »

ImmunArray Executive Team (12)

Name Title Board Seat Contact Info
Nathan Hunt Vice President, Quality & Regulatory and Market Manager Neurological Diseases
You’re viewing 1 of 12 executive team members. Get the full list »

ImmunArray Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial